Free Research Reports on CLF, IMGN, SVNT and TSYS Issued by the Bedford Report
November 05 2012 - 7:45AM
Marketwired
The Bedford Report has released new equity reports today. As a
leading provider of free in depth reports and timely market
updates, Bedford is an essential resource for hundreds of thousands
of investors across the country.
Cliffs Natural Resources Inc. (NYSE: CLF)
shares have fallen sharply this past week after reporting third
quarter profit declined 86 percent to $85.1 million. For 2012, the
company has reduced its U.S. iron ore sales volume expectation to
22 million tons from its previous expectation of 23 million
tons.
Find out more about Cliffs Natural
Resources including full access to the free equity report at:
www.BedfordReport.com/CLF
ImmunoGen, Inc. (NASDAQ: IMGN) shares
declined 16 percent after reporting losses widened to $25.2 million
in the fiscal first quarter, from to a net loss of $19.5 million in
the year-ago quarter. The company expects to file for marketing
approval of its cancer drug T-DM1 in 2015.
Find out more about ImmunoGen including
full access to the free equity report at:
www.BedfordReport.com/IMGN
Savient Pharmaceuticals, Inc. (NASDAQ:
SVNT) earlier this month received positive opinion from the
European Medicines Agency's Committee for Medicinal Products for
Human Use recommending approval of a marketing authorization in the
European Union for KRYSTEXXA. The company will release third
quarter results on November 8, 2012.
Find out more about Savient
Pharmaceuticals including full access to the free equity
report at: www.BedfordReport.com/SVNT
TeleCommunication Systems, Inc. (NASDAQ:
TSYS) shares of the wireless communications company soared 17
percent Friday after reporting third quarter revenue increased 24
percent to a record of $140.1 million.
Find out more about TeleCommunication
Systems including full access to the free equity report at:
www.BedfordReport.com/TSYS
Disclaimer: Equity News Circuit is not a registered investment
advisor, and nothing in this report is intended as a solicitation
to buy or sell any security. A third party, bedfordreport.com, has
paid Equity News Circuit four hundred and fifty dollars for the
publication of this news release. Neither Equity News Circuit, nor
the hiring party, have a financial relationship with any company
whose stock is mentioned in this release.
Contact Information: Equity News Circuit Email Contact
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Jul 2024 to Aug 2024
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Aug 2023 to Aug 2024